Moderna Q3 EPS $(9.53) May Not Be Comparable To $(1.93) Estimate, Sales $1.83B Beat $1.40B Estimate
Portfolio Pulse from Benzinga Newsdesk
Moderna reported Q3 losses of $(9.53) per share, missing the analyst consensus estimate of $(1.93) by 393.78 percent. This is a 476.68 percent decrease over earnings of $2.53 per share from the same period last year. However, the company reported quarterly sales of $1.83 billion, beating the analyst consensus estimate of $1.40 billion by 30.79 percent.
November 02, 2023 | 10:35 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Moderna's Q3 earnings per share were significantly lower than expected, but sales beat estimates.
Moderna's Q3 earnings per share were significantly lower than expected, which could negatively impact the stock price. However, the company's sales beat estimates, which could offset some of the negative impact.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100